CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-08 | Hasara Garrison J. CFO and Treasurer | Shares withheld for taxes | −1,470,478 | $0.34 | $500K | 4,059,044 |
| 2017-03-08 | Hasara Garrison J. CFO and Treasurer | Option exercise · Restricted Stock Units | −3,500,000 | 0 | ||
| 2017-03-08 | Hasara Garrison J. CFO and Treasurer | Option exercise · Restricted Stock Units | −3,500,000 | 0 | ||
| 2017-03-08 | VIRCA NICHOLAS J President and CEO | Option exercise | +15,041,738 | 15,041,738 | ||
| 2017-03-08 | VIRCA NICHOLAS J President and CEO | Shares withheld for taxes | −6,314,219 | $0.34 | $2.1M | 8,727,519 |
| 2017-03-08 | VIRCA NICHOLAS J President and CEO | Option exercise · Restricted Stock Units | −15,041,738 | 0 | ||
| 2017-03-08 | Cross Stefan Director | Option exercise | +300,000 | 300,000 | ||
| 2017-03-08 | Cross Stefan Director | Option exercise | +300,000 | 600,000 | ||
| 2017-03-08 | Cross Stefan Director | Option exercise · Restricted Stock Units | −300,000 | 0 | ||
| 2017-03-08 | Cross Stefan Director | Option exercise · Restricted Stock Units | −300,000 | 0 | ||
| 2017-03-08 | Ono Richard Dana Director | Option exercise | +300,000 | 300,000 | ||
| 2017-03-08 | Ono Richard Dana Director | Shares withheld for taxes | −118,800 | $0.34 | $40K | 181,200 |
| 2017-03-08 | Ono Richard Dana Director | Option exercise | +300,000 | 481,200 | ||
| 2017-03-08 | Ono Richard Dana Director | Shares withheld for taxes | −118,800 | $0.34 | $40K | 362,400 |
| 2017-03-08 | Ono Richard Dana Director | Option exercise | +150,000 | 512,400 | ||
| 2017-03-08 | Ono Richard Dana Director | Shares withheld for taxes | −59,400 | $0.34 | $20K | 453,000 |
| 2017-03-08 | Ono Richard Dana Director | Option exercise · Restricted Stock Units | −300,000 | 0 | ||
| 2017-03-08 | Ono Richard Dana Director | Option exercise · Restricted Stock Units | −300,000 | 0 | ||
| 2017-03-08 | Ono Richard Dana Director | Option exercise · Restricted Stock Units | −150,000 | 0 | ||
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise | +4,750,569 | 192,645,799 |
Page 5 of 9 · 165 trades